PubRank

Patrick S Kamath

Author PubWeight™ 123.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008 6.67
2 Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 2013 5.19
3 Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010 5.00
4 The Budd-Chiari syndrome. N Engl J Med 2004 3.95
5 Acute-on chronic liver failure. J Hepatol 2012 3.74
6 Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002 3.50
7 MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005 2.99
8 Splanchnic artery aneurysms. Mayo Clin Proc 2007 2.55
9 Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007 2.36
10 Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 2006 2.34
11 Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology 2014 2.27
12 Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008 2.26
13 Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 2006 2.25
14 Mesenteric venous thrombosis. Mayo Clin Proc 2013 2.09
15 A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology 2008 2.02
16 Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004 1.96
17 Performance standards for therapeutic abdominal paracentesis. Hepatology 2004 1.93
18 Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004 1.87
19 Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007 1.86
20 A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004 1.83
21 Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl 2003 1.83
22 Hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013 1.81
23 Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012 1.74
24 A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008 1.65
25 Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003 1.65
26 Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol 2010 1.62
27 MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004 1.57
28 Intensive care of the patient with cirrhosis. Hepatology 2011 1.54
29 Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003 1.47
30 Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl 2007 1.39
31 Medical and surgical treatment options for polycystic liver disease. Hepatology 2010 1.39
32 Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003 1.37
33 Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 2009 1.37
34 New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 2013 1.35
35 Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008 1.35
36 Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013 1.33
37 Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care 2011 1.33
38 Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003 1.30
39 Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol 2003 1.24
40 Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014 1.16
41 Congenital heart disease and the liver. Hepatology 2012 1.12
42 Ectopic varices in the gastrointestinal tract: short- and long-term outcomes of percutaneous therapy. Cardiovasc Intervent Radiol 2005 1.09
43 Embolization of spontaneous portosystemic shunts for management of severe persistent hepatic encephalopathy. Hepatology 2013 1.09
44 Medical and ethical aspects of long-term enteral tube feeding. Mayo Clin Proc 2005 1.05
45 Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc 2006 1.02
46 Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005 1.02
47 Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc 2005 1.02
48 Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 2003 1.01
49 Bacterial infections in end-stage liver disease: current challenges and future directions. Gut 2012 1.00
50 Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc 2011 0.98
51 Natural history of cirrhosis. Curr Gastroenterol Rep 2013 0.94
52 Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology 2015 0.94
53 Duodenal diverticulosis in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2006 0.91
54 Cancer antigen 125 in patients with chronic liver disease. Mayo Clin Proc 2002 0.91
55 Impact factor: misused and overhyped? Hepatology 2009 0.90
56 Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment? Arch Pathol Lab Med 2004 0.89
57 Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transpl 2003 0.88
58 Race and receipt of liver transplantation: location matters. Liver Transpl 2010 0.88
59 Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol 2006 0.88
60 Heart and liver disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation. Mayo Clin Proc 2004 0.87
61 Hematological malignancy manifesting as ascites. Nat Clin Pract Gastroenterol Hepatol 2005 0.86
62 Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort. BMJ Open 2013 0.83
63 Dysphagia lusoria. Mayo Clin Proc 2012 0.83
64 Cardiac surgery in kidney and liver transplant recipients. Mayo Clin Proc 2006 0.82
65 Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int 2013 0.82
66 Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl 2006 0.82
67 Cardiomyopathy associated with celiac disease. Mayo Clin Proc 2005 0.82
68 Acute-on-chronic liver failure: what are the implications? Curr Gastroenterol Rep 2012 0.81
69 Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology 2011 0.80
70 Wilson Disease--keeping the bar for diagnosis raised. Hepatology 2005 0.80
71 Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy. Liver Int 2010 0.79
72 Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl 2007 0.79
73 Antithrombotic therapy and invasive procedures. N Engl J Med 2013 0.79
74 Hepatopulmonary syndrome and portopulmonary hypertension. Hepatol Res 2009 0.79
75 The need for better clinical trials. Hepatology 2008 0.78
76 Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding. Liver Int 2010 0.78
77 Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006 0.78
78 Lack of significant liver enzyme elevation and gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectomy: a population-based study. Surgery 2011 0.78
79 Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective? Gastroenterology 2008 0.77
80 Liver transplantation for Budd-Chiari syndrome: when is it really necessary? Liver Transpl 2008 0.76
81 Current staging and diagnosis of gastroesophageal varices. Clin Liver Dis 2010 0.75
82 Reply to: "Acute-on-chronic liver failure - its definition remains unclear". J Hepatol 2013 0.75
83 Managing septic shock in patients with cirrhosis: the role of adrenal insufficency. Gastroenterology 2007 0.75
84 An evidence-based medicine approach to beta-blocker therapy in patients with cirrhosis. Am J Med 2004 0.75
85 Is there life in MARS? Hepatology 2002 0.75
86 Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int 2015 0.75
87 Diagnostic and therapeutic advances in hepatology: a new feature in the journal. Hepatology 2010 0.75
88 Skin signs as the presenting manifestation of severe nutritional deficiency: report of 2 cases. Arch Dermatol 2004 0.75
89 Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management. Am J Clin Oncol 2017 0.75
90 Publications in Hepatology: is there a pro-United States bias? Hepatology 2011 0.75
91 Born to be wild or just confused? Genetic predisposition to hepatic encephalopathy. Gastroenterology 2011 0.75
92 Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis. Mayo Clin Proc 2003 0.75
93 Amelioration of high cardiac output and pulmonary hypertension by occlusion of congenital porto-systemic shunt. Circulation 2012 0.75
94 Caroli syndrome. Mayo Clin Proc 2013 0.75
95 A bad streak. Gastroenterology 2012 0.75
96 Working out the bug in the accordion. Gastroenterology 2009 0.75